|
|
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- NHS Trusts (England) - Medical Director
- NHS Trusts (England) - Chief Executive
|
|
|
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- Special Health Authorities
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- Primary Care Networks
- GP Practices 1
|
| Action category: |
|
Important information for immediate action
|
| Title: |
|
COVID-19 Research and treatment trials
|
| Broadcast content: |
|
Thank you for your efforts in facilitating research on COVID-19 in the NHS, which has informed clinical practice worldwide. The attached outlines how important it is that COVID-19 patients are always invited to join the urgent public health (UPH) studies. It explains that RECOVERY will continue to be supported as the national clinical trial platform for COVID-19 phase III therapeutics trials and will also be extended to include phase II trials. And that with upcoming vaccine studies and a need to restart non-COVID-19 research that was paused it is vital that research delivery staff and clinical academics return from frontline and other duties and resume their research.
|